Medical Devices Russia

Russia Preeclampsia Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Russia Preeclampsia Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Test, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Russia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $17.1 Mn Placeholder estimate
Estimate 2025 $18.2 Mn 1.1% of the global market
Projected 2034 $33.0 Mn 80.8% Adds $14.7 Mn over 9 forecast years
CAGR 2025–2034 6.8% Faster than 18% of 147 Medical Devices markets here
Key players 5
  • Russia is 1.14% of the global market.
  • In Europe, the largest is Germany at $56.7 Mn.
  • Fastest growing: Italy at 6.8% a year.
  • Russia ranks 6th of 6 by size in Europe.

Market size projection

Russia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$14.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Preeclampsia Diagnostics Market market size by year, Russia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $17.1 Mn — —
2025 (base) $18.2 Mn +$1.2 Mn —
2026 (forecast) $19.5 Mn +$1.2 Mn +6.8%
2027 (forecast) $20.8 Mn +$1.3 Mn +14.1%
2028 (forecast) $22.2 Mn +$1.4 Mn +21.8%
2029 (forecast) $23.7 Mn +$1.5 Mn +30.1%
2030 (forecast) $25.4 Mn +$1.6 Mn +38.9%
2031 (forecast) $27.1 Mn +$1.7 Mn +48.4%
2032 (forecast) $28.9 Mn +$1.8 Mn +58.5%
2033 (forecast) $30.9 Mn +$2.0 Mn +69.3%
2034 (forecast) $33.0 Mn +$2.1 Mn +80.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Russia Preeclampsia Diagnostics Market Analysis at a glance
Market size, 2025$18.2 Mn placeholder estimate
Forecast, 2034$33.0 Mn placeholder estimate
Growth (CAGR), 2025–20346.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, use and end user (see all)
Key playersRoche Diagnostics, Thermo Fisher Scientific Inc., Perkin Elmer, Siemens Healthineers, Quidel Corporation (see all)
Regulator in RussiaRoszdravnadzorSource: Roszdravnadzor. Checked 14 Nov 2026.
Active clinical trials1 in RussiaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Russia. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Russia Preeclampsia Diagnostics Market Analysis Executive Summary

Preeclampsia diagnostics are blood tests and monitoring tools that predict or detect dangerous high blood pressure in pregnancy.

Key segments of the preeclampsia Diagnostics market include test (sFlt-1/PlGF Ratio Tests, PlGF Tests and Blood Pressure Monitoring) and use (Screening, Diagnosis and Prognosis).

Bar chart: Russia Preeclampsia Diagnostics market size, 2024–2034, placeholder estimates. $17.1 Mn in 2024, $18.2 Mn in 2025 and $33.0 Mn in 2034, 6.8% CAGR.
Russia Preeclampsia Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Russia Preeclampsia Diagnostics Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the preeclampsia Diagnostics market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the preeclampsia Diagnostics market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the preeclampsia Diagnostics market.

Competitive Landscape for Preeclampsia Diagnostics Market in Russia

The preeclampsia Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Preeclampsia Diagnostics Market in Russia

Preeclampsia Diagnostics in Russia: rules, payment and research

Medical devices are registered by Roszdravnadzor, the federal health care regulator.⁠[1] Compulsory medical insurance (OMS) pays for a guaranteed package of free care, through the Federal Compulsory Medical Insurance Fund.⁠[2] ClinicalTrials.gov lists 1 study on Preeclampsia Diagnostics that is recruiting, active or about to start in Russia.⁠[3]

[1] Roszdravnadzor. Checked 14 Nov 2026.

[2] Federal Compulsory Medical Insurance Fund. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Russia. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how preeclampsia Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Russia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Preeclampsia Diagnostics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Preeclampsia Diagnostics in context

Russia compared

  • Health spending per person: 1,003 US$ per person (2023). World: 1,317 US$ per person (2023). 6th highest of the 6 countries we cover in Europe.[1]
  • Doctors: 5.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 17.8% of people (2025). World: 10.4% of people (2025). 6th highest of the 6 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 18 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Preeclampsia Diagnostics market in Russia?
Placeholder estimate: about $18.2 Mn in 2025, rising to about $33.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Preeclampsia Diagnostics market in Russia growing?
Placeholder estimate: about 6.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Preeclampsia Diagnostics market report cover?
The report splits the market by test (sFlt-1/PlGF Ratio Tests, PlGF Tests, Blood Pressure Monitoring, Urine Protein Tests), use (Screening, Diagnosis, Prognosis) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Preeclampsia Diagnostics market?
Key players include Roche Diagnostics, Thermo Fisher Scientific Inc., Perkin Elmer, Siemens Healthineers and Quidel Corporation.
What is driving the Preeclampsia Diagnostics market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the preeclampsia Diagnostics market. New products designed around women's biology and digital care are improving access.
Who regulates Preeclampsia Diagnostics in Russia?
Medical devices are registered by Roszdravnadzor, the federal health care regulator. Source: Roszdravnadzor. Checked 14 Nov 2026.
How is healthcare paid for in Russia?
Compulsory medical insurance (OMS) pays for a guaranteed package of free care, through the Federal Compulsory Medical Insurance Fund. Source: Federal Compulsory Medical Insurance Fund. Checked 14 Nov 2026.
How many clinical trials on Preeclampsia Diagnostics are running in Russia?
1 study is recruiting, active or about to start in Russia, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Russia. Retrieved 12 Nov 2026.
How much research is published on Preeclampsia Diagnostics?
PubMed lists 7,556 papers on Preeclampsia Diagnostics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Russia

See all

Related on maternal and diagnostics and lab testing

See the topic